Moxetumomab pasudotox

Moxetumomab pasudotox ?
Monoclonal antibody
Type Whole antibody
Source Mouse
Target CD22
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 1020748-57-5 N
ATC code None
Chemical data
Formula C2804H4339N783O870S14 
Mol. mass 63.5 kDa
 N(what is this?)  (verify)

Moxetumomab pasudotox is a mouse monoclonal antibody designed for the treatment of cancer.[1]

Moxetumomab pasudotox was developed by MedImmune, Inc.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Moxetumomab Pasudotox". American Medical Association. http://www.ama-assn.org/resources/doc/usan/moxetumomab-pasudotox.pdf.